Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma

Oncology Research

Volumn 9, Issue 8, 1997, Pages 419-431

  Festuccia, Claudio ^a,b   Teti, Anna ^a,b   Bianco, Paolo ^a,b   Guerra, Fulvio ^a,b   Vicentini, Carlo ^a,b   Tennina, Rita ^a,b   Villanova, Ida ^a,b   Sciortino, Giancarlo ^a   Bologna, Mauro ^a,b  

^a Department of Experimental Medicine ^*  (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Bone metastasis; Invasion; Prostatic cancer; Urokinase type plasminogen activator

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH PROMOTOR; UROKINASE;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION; CULTURE MEDIUM; CYTOLOGY; DISEASE COURSE; DRUG EFFECT; EPITHELIUM; HUMAN; MALE; METABOLISM; OSTEOBLAST; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; EPITHELIUM; GROWTH SUBSTANCES; HUMANS; MALE; NEOPLASM STAGING; OSTEOBLASTS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031305088     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Boring, C. C.; Squires, T. S.; Tong, T.; Montgomery, S. Cancer statistics 1994. CA Cancer J. Clin. 44:7-26; 1994.
2. Galasko, C. B. S. Mechanisms of bone destruction in the development of skeletal métastases. Nature 263:507-508; 1976.
3. Jacobs, S. C. Spread of prostatic carcinoma to bone. Urology 21:337-342; 1983.
4. Chackel-Roy, M.; Niemeyer, C.; Moore, M.; Zetter, B. R. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J. Clin. Invest. 84:4349; 1989.
5. Wu, H. C.; Hsieh, J. T.; Cleave, M. E.; Brown, N. M.; Pathak, S.; Chung, L. W. Derivation of androgenindependent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells. Int. J. Cancer 57:406-412; 1994.
6. Lang, S. H.; Miller, W. R.; Habib, F. K. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate 27:287293; 1995.
7. Jacobs, S. C.; Pikna, D.; Lawson, R. K. Prostaticosteoblastic factor. Invest. Urol. 17:195-198; 1979.
8. Jacobs, S. C.; Lawson, R. K. Mitogenic factor in human prostate extracts. Urology 16:488-491; 1980.
9. Koutsillieris, M.; Rabbani, S. A.; Goltzman, D. Selective osteoblast mitogenes can be extracted from prostatic tissue. Prostate 9:109-115; 1986.
10. Koutsillieris, M.; Rabbani, S. A.; Bennett, H. P.; Goltzman, D. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J. Clin. Invest. 80:941-947; 1987.
11. Koutsillieris, M.; Frenetic, G.; Lazure; C.; Lehoux, J. G.; Govidan, M. W.; Polychronakos, C. Urokinase-type plasminogen activator: A paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic métastases. Anticancer Res. 13:481-486; 1993.
12. Koutsillieris, M.; Souria, A.; Pellettier, G.; Doillon, C. J. Three-dimensional type I collagen system for the study of osteoblastic métastases produced by metastatic prostate cancer. J. Bone Miner. Res. 9:1823-1832; 1994.
13. Hienert, G.; Kirchheimer, J. C.; Pfluger, H.; Binder, B. R. Urokinase-type plasminogen activator as a marker for the formation of distant métastases in prostatic carcinomas. J. Urol. 140:1466-1469; 1988.
14. Mignatti, P.; Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:161-195; 1993.
15. Stearns, M. E.; Wang, M.; Stearns, M. Proteases and invasion by metastatic tumor cells-clinical implications for prostatic carcinoma. Int. J. Oncol. 4:1013-1023; 1994.
16. Pfluger, H.; Kirchmeier, J. C.; Hienert, G.; Binder, J. Urokinase: A specific marker of metastasation in prostate carcinoma. J. Urol. 137:114A; 1987.
17. Hollas, W.; Hoosein, N.; Chung, L. W.; Mazar, A.; Henki, J.; Kariko, K.; Barnathan, E. S.; Boyd, D. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thromb. Haemost. 68:662-666; 1992.
18. Festuccia, C.; Vicentini, C.; Firna, N.; Di Pasquale, B.; Aceto, G.; Zazzeroni, F.; Miano, L.; Bologna, M. Plasminogen activator activities in short term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncol. Res. 7: 131-138; 1995.
19. Achbarou, A.; Kaiser, S.; Tremblay, G.; Stemarie, L. G.; Brodt, P.; Goltzman, D.; Rabbani, S. A. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res. 54:2372-2377; 1994.
20. Laiho, M.; Keski-Oia, J. Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res. 49:2533-2553; 1989.
21. Blasi, F.; Vassalli, J.D.; Dano, K. Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors. J. Cell Biol. 104:801-804; 1987.
22. Rabbani, S. A.; Desjardins, J.; Bell, A. W.; Mazar, A.; Henkin, J.; Goltzman, D. An amino-terminal fragment of urokinase isolated from a human prostate cancer cell line (PC3) is mitogenic for osteoblast-like cells. Biochem. Biophys. Res. Commun. 173:1058-1064; 1990.
23. Rabbani, S. A.; Mazar, A. P.; Bernier, S. M.; Haq, M.; Bolivar, I.; Henkin, J.; Goltzman, D. Structural requirements for growth factor activity of the aminoterminal domain of urokinase. J. Biol. Chem. 267:14151-14156; 1992.
24. Bologna, M.; Vicentini, C.; Festuccia, C.; Muzi, P.; Napolitano, T.; Biordi, L.; Miano, L. Short term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis. Eur. Urol. 15:243-247; 1988.
25. Teti, A.; Tarquillo, M.; Grano, M.; Colucci, S.; Laforgia, A.; Mangini, F; Zambonin-Zallone, A. Effects of calciumphosphate-based materials on proliferation and alkaline phosphatase activity of newborn rat periostea! cells in vitro. J. Dent. Res. 70:997-1000; 1991.
26. Gehron-Robey, P.; Termine, J. D. Human bone cells in vitro. Calcif. Tissue Int. 37:453-460; 1985.
27. Moosman, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Methods 65:55-63; 1983.
28. Goltzman, D.; Bolivar, I.; Rabbani, S. A. Studies on the pathogenesis of osteoblastic métastases by prostate cancer. Adv. Exp. Med. Biol. 324:165-171; 1992.
29. Franceschi, R.; James, W.; Zerlauth, G. 1,25dihydroxyvitamin D3 specific regulation of growth, morphology and fibronectin in a human osteosarcoma cell line. J. Cell. Physiol. 123:401-409; 1985.
30. Franceschi, R.; Linson, C.; Peter, T.; Romano, P. Regulation of cellular adhesion and fibronectin sysnthesis by 1,25dihydroxyvitamin D3. J. Biol. Chem. 262:4165-4171: 1987.
31. Franceschi, R.; Romano, P.; Park, K. Regulation of type I collagen sysnthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. J. Biol. Chem. 262:18938-18945; 1988.
32. Andrianarivo, A. G.; Robinson, J. A.; Mann, K. G.; Tracy, R. P. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG63 cells. J. Cell. Physiol. 153:256-265; 1992.
33. Festuccia, C.; Bologna, M.; Vicentini, C.; Tacconelli, A.; Miano, R.; Violini, S.; Mackay, A. R. Increased matrix metalloproteinase-9 secretion in short term tissue cultures of prostatic tumor cells. Int. J. Cancer 69:386-393; 1996.
34. Naldini, L.; Tamagnon, L.; Vigna, E.; Sachs, M.; Hartmann, G.; Bierchmeier, W.; Daikuhara, Y.; Tsubouchi, H.; Blasi, F.; Comoglio, P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/ scatter factor. EMBO J. 11:4825-4833; 1992.
35. Gehron-Robey, P.; Young, M.; Flanders, K.; Roche, N.; Kondaiah, P.; Reddi, A.; Termine, J.; Sporn, M.; Roberts, A. Osteoblasts synthesize and respond to transforming growth factor-type beta in vitro. J. Cell. Physiol. 105:457-463; 1987.
36. Campbell, P. G.; Novak, J. F.; Yanosick, T. B.; McMosier, J. H. Involvement of the plasmin system in dissociation of the insulin-like growth factor binding protein complex. Endocrinology 130:1401-1412; 1992.
37. Campbell, P. G.; Novak, J. F.; Winess, K.; Welion, P. E. Localization of plasmin activity on osteosarcoma cells: Cell surface proteolysis of insulin-like growth factor binding protein. Growth Regul. 3:95-98; 1993.
38. Campbell, P. G.; Novak, J. F. Insulin-like growth factor binding protein inhibits IGF action on human osteosarcoma cells. J. Cell. Physiol. 149:293-300; 1991.
39. Rabbani, S. A.; Rajwans, N.; Achbarou, A.; Murthy, K. K.; Goltzman, D. Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS Lett. 338:69-74; 1994.
40. Iwamura, M.; Gershagen, G.; Lapets, O.; Moynes, R.; Abrahamsson, P. A.; Cockett, A. T.; DFfeftos, L. G.; Si Santagnese, P. A. Immunohistochemical localization of parathyroid hormone related protein in prostatic intraepithelial neoplasia. Hum. Pathol. 26:797-801; 1995.